规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:1000-3000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
Nephrin Antibody detects endogenous levels of total Nephrin.
RRID:
AB_2841001
引用格式: Affinity Biosciences Cat# DF7501, RRID:AB_2841001.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

CNF; Nephrin; Nephrosis 1 congenital Finnish type; Nephrosis 1, congenital, Finnish type (nephrin); NPHN; NPHN_HUMAN; NPHS 1; Nphs1; Renal glomerulus specific cell adhesion receptor; Renal glomerulus-specific cell adhesion receptor;

抗原和靶标

免疫原:

A synthesized peptide derived from human Nephrin

基因/基因ID:

文献引用

1). C‐reactive protein inhibits C3a/C3aR‐dependent podocyte autophagy in favor of diabetic kidney disease. The FASEB Journal, 2022 (PubMed: 35503088) [IF=4.4]

Application: IHC    Species: Rat    Sample: glomeruli

FIGURE 5Podocyte injury and C3aR expression were evaluated in STZ-diabetic DKD rats. (A) Representative images of nephrin and WT1 expressed in glomeruli of DKD rats by IHC staining (n = 4). (B) Representative images of C3aR expressed in glomeruli of DKD rats by IHC staining (n = 4). (C and D) Quantitative analysis of nephrin, WT1 and C3aR was performed using Image-Pro Plus 6.0 software (n = 4, more than 20 glomeruli). (E and F) The colocalization of nephrin and C3aR in human renal biopsies and DKD kidney tissues by a commercial double staining kit. 400× original magnification; scale bar, 50 µm. Data are presented as the means ± SEM, and p < .05 was considered to be statistically significant

2). ADAM metallopeptidase domain 10 knockdown enables podocytes to resist high glucose stimulation by inhibiting pyroptosis via MAPK pathway. Experimental and Therapeutic Medicine, 2023 (PubMed: 37153901) [IF=2.4]

Application: WB    Species: Mouse    Sample:

Figure 2 ADAM10 knockdown inhibits HG-induced podocyte apoptosis. (A) Podocyte markers were evaluated using western blot analysis. (B) Podocyte apoptosis was evaluated using the TUNEL assay. (C) Apoptotic rate was obtained according to the results of the TUNEL assay. (D) Expression levels of proteins related to apoptosis were assessed using western blot analysis. ***P

3). Sericin suppresses high glucose-induced EMT in mouse podocytes via miR-30a-5p and its target Snai1. Pakistan journal of pharmaceutical sciences, 2023 (PubMed: 37869922) [IF=0.7]

4). Protective Effect of Keluoxin against Diabetic Nephropathy in Type 2 Diabetic Mellitus Models. Evidence-based complementary and alternative medicine : eCAM, 2021 (PubMed: 34712350)

Application: WB    Species: Rat    Sample: renal tissues

Figure 3 (a) Effect of Keluoxin and Irbesartan on LC3, p62, and nephrin proteins in renal tissues of DN-induced rats. (a) The levels of LC3, p62, and nephrin proteins from renal tissues were detected by western blot and normalized to β-actin. (b) The expression of LC3-II. (c) The ratio of LC3-ll/LC3-l. (d) The expression of p62. (e) The expression of nephrin protein. (f) Mean fluorescence intensity of nephrin was measured for each group.  ∗P < 0.05 and  ∗∗P < 0.01 versus the normal group;  #P < 0.05 and  ##P < 0.01 versus the model group.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.